Acetyl-CoA carboxylase α gene and breast cancer susceptibility

Carcinogenesis

Volumn 25, Issue 12, 2004, Pages 2417-2424

  Sinilnikova, Olga M ^a,b   Ginolhac, Sophie M ^a   Magnard, Clémence ^c   Léoné, Mélanie ^a,b   Anczukov, Olga ^a,c   Hughes, David ^a   Moreau, Karen ^c   Thompson, Deborah ^a   Coutanson, Christine ^a   Hall, Janet ^a   Romestaing, Pascale ^d   Gérard, Jean Pierre ^d,e   Bonadona, Valérie ^f   Lasset, Christine ^f   Goldgar, David E ^a   Joulin, Virginie ^f   Venezia, Nicole Dalla ^c   Leonoir, Gilbert M ^f  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e CENTRE ANTOINE LACASSAGNE   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; BRCA1 PROTEIN; BRCA2 PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; INTRON; MAJOR CLINICAL STUDY; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ACETYL-COA CARBOXYLASE; ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 10344251473     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh273     Document Type: Article

References (59)

1. Magnard,C., Bachelier,R., Vincent,A., Jaquinod,M., Kieffer,S., Lenoir,G.M. and Venezia,N.D. (2002) BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains. Oncogene 21, 6729-6739.
2. Brownsey,R.W., Zhande,R. and Boone,A.N. (1997) Isoforms of acetyl-CoA carboxylase: structures, regulatory properties and metabolic functions. Biochem. Soc. Trans., 25, 1232-1238.
3. Kim,K.H. (1997) Regulation of mammalian acetyl-coenzyme A carboxylase. Annu. Rev. Nutr., 17, 77-99.
4. Luo,X.C., Park,K., Lopez-Casillas,F. and Kim,K.H. (1989) Structural features of the acetyl-CoA carboxylase gene: mechanisms for the generation of mRNAs with 5′ end heterogeneity. Proc. Natl Acad. Sci. USA, 86, 4042-4046.
5. Luo,X.C. and Kim,K.H. (1990) An enhancer element in the house-keeping promoter for acetyl-CoA carboxylase gene. Nucleic Acids Res., 18, 3249-3254.
6. Lopez-Casillas,F., Ponce-Castaneda,M.V. and Kim,K.H. (1991) In vivo regulation of the activity of the two promoters of the rat acetyl coenzyme-A carboxylase gene. Endocrinology, 129, 1049-1058.
7. Abu-Elheiga,L., Jayakumar,A., Baldini,A., Chirala,S.S. and Wakil,S.J. (1995) Human acetyl-CoA carboxylase: characterization, molecular cloning, and evidence for two isoforms. Proc. Natl Acad. Sci. USA, 92, 4011-4015.
8. Ha,J., Daniel,S., Kong,I.S., Park,K., Tae,H.J. and Kim,K.H. (1994) Cloning of human acetyl-CoA carboxylase cDNA. Eur. J. Biochem. 219, 297-306.
9. Tae,H.J., Luo,X. and Kim,K.H. (1994) Roles of CCAAT/enhancer-binding protein and its binding site on repression and derepression of acetyl-CoA carboxylase gene. J. Biol. Chem., 269 10475-10484.
10. Daniel,S. and Kim,K.H. (1996) Sp1 mediates glucose activation of the acetyl-CoA carboxylase promoter. J. Biol. Chem., 271, 1385-1392.
11. Travers,M.T., Vallance,A.J., Gourlay,H.T., Gill,C.A., Klein,I., Bottema,C.B. and Barber,M.C. (2001) Promoter I of the ovine acetyl-CoA carboxylase-alpha gene: an E-box motif at -114 in the proximal promoter binds upstream stimulatory factor (USF)-1 and USF-2 and acts as an insulin-response sequence in differentiating adipocytes. Biochem. J., 359, 273-284.
12. Mao,J., Marcos,S., Davis,S.K., Burzlaff,J. and Seyfert,H.M. (2001) Genomic distribution of three promoters of the bovine gene encoding acetyl-CoA carboxylase alpha and evidence that the nutritionally regulated promoter I contains a repressive element different from that in rat. Biochem. J., 358, 127-135.
13. Yin,L., Zhang,Y. and Hillgartner,F.B. (2002) Sterol regulatory element-binding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transcription in hepatocytes. J. Biol. Chem., 277, 19554-19565.
14. Barber,M.C. and Travers,M.T. (1998) Elucidation of a promoter activity that directs the expression of acetyl-CoA carboxylase alpha with an alternative N-terminus in a tissue-restricted fashion. Biochem. J. 333, 17-25.
15. Mao,J., Molenaar,A.J., Wheeler,T.T. and Seyfert,H.M. (2002) STAT5 binding contributes to lactational stimulation of promoter III expressing the bovine acetyl-CoA carboxylase alpha-encoding gene in the mammary gland. J. Mol. Endocrinol., 29, 73-88.
16. Barber,M.C., Vallance,A.J., Kennedy,H.T. and Travers,M.T. (2003) Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site. Biochem. J., 375, 489-501.
17. Travers,M.T., Vallance,A.J., Clegg,R.A., Thomson,R., Price,N.T. and Barber,M.C. (2003) Characterisation of an N-terminal variant of acetyl-CoA carboxylase-alpha: expression in human tissues and evolutionary aspects. Biochem. Biophys. Acta, 1634, 97-106.
18. Mao,J., Chirala,S.S. and Wakil,S.J. (2003) Human acetyl-CoA carboxylase 1 gene: presence of three promoters and heterogeneity at the 5′-untranslated mRNA region. Proc. Natl Acad. Sci. USA, 100 7515-7520.
19. Witters,L.A., Widmer,J., King,A.N., Fassihi,K. and Kuhajda,F. (1994) Identification of human acetyl-CoA carboxylase isozymes in tissue and in breast cancer cells. Int. J. Biochem., 26, 589-594.
20. Milgraum,L.Z., Witters,L.A., Pasternack,G.R. and Kuhajda,F.P. (1997) Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin. Cancer Res., 3, 2115-2120.
21. Alo,P.L., Visca,P., Trombetta,G., Mangoni,A., Lenti,L., Monaco,S., Botti,C., Serpieri,D.E. and Di Tondo,U. (1999) Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori, 85, 35-40.
22. Nakamura,I., Kimijima,I., Zhang,G.J., Onogi,H., Endo,Y., Suzuki,S., Tuchiya,A., Takenoshita,S., Kusakabe,T. and Suzuki,T. (1999) Fatty acid synthase expression in Japanese breast carcinoma patients. Int. J. Mol. Med., 4, 381-387.
23. Wang,Y., Kuhajda,F.P., Li,J.N., Pizer,E.S., Han,W.F., Sokoll,L.J. and Chan,D.W. (2001) Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett., 167, 99-104.
24. Alo,P.L., Visca,P., Botti,C., Galati,G.M., Sebastiani,V., Andreano,T., Di Tondo,U. and Pizer,E.S. (2001) Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am. J. Clin. Pathol., 116 129-134.
25. Kumar-Sinha,C., Ignatoski,K.W., Lippman,M.E., Ethier,S.P. and Chinnaiyan,A.M. (2003) Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res., 63, 132-139.
26. Slamon,D.J., Godolphin,W., Jones,L.A., Holt,J.A., Wong,S.G., Keith,D.E., Levin,W.J., Stuart,S.G., Udove,J. and Ullrich,A. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
27. Isola,J., Chu,L., DeVries,S., Matsumura,K., Chew,K., Ljung,B.M. and Waldman,F.M. (1999) Genetic alterations in ERBB2-amplified breast carcinomas. Clin. Cancer Res., 5, 4140-4145.
28. Albanell,J., Bellmunt,J., Molina,R. et al. (1996) Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis. Anticancer Res., 16, 1027-1032.
29. Kuhajda,F.P., Jenner,K., Wood,F.D., Hennigar,R.A., Jacobs,L.B., Dick,J.D. and Pasternack,G.R. (1994) Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc. Natl Acad. Sci. USA, 91, 6379-6383.
30. Pizer,E.S., Wood,F.D., Heine,H.S., Romantsev,E., Pasternack,G.R. and Kuhajda,F.P. (1996) Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res., 56, 1189-1193.
31. Pizer,E.S., Chrest,F.J., DiGiuseppe,J.A. and Han,W.F. (1998) Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res., 58, 4611-4615.
32. Pizer,E.S., Thupari,J., Han,W.F., Pinn,M.L., Chrest,F.J., Frehywot,G.L., Townsend,C.A. and Kuhajda,F.P. (2000) Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 60, 213-218.
33. Kuhajda,F.P., Pizer,E.S., Li,J.N., Mani,N.S., Frehywot,G.L. and Townsend,C.A. (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl Acad. Sci. USA, 97, 3450-3454.
34. Thupari,J.N., Pinn,M.L. and Kuhajda,F.P. (2001) Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem. Biophys. Res. Commun., 285, 217-223.
35. Zhou,W., Simpson,P.J., McFadden,J.M., Townsend,C.A., Medghalchi,S.M., Vadlamudi,A., Pinn,M.L., Ronnett,G.V. and Kuhajda,F.P. (2003) Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res., 63, 7330-7337.
36. Bianchini,F., Kaaks,R. and Vainio,H. (2002) Overweight, obesity, and cancer risk. Lancet Oncol., 3, 565-574.
37. Serova,O., Montagna,M., Torchard,D., Narod,S.A., Tonin,P., Sylla,B., Lynch,H.T., Feunteun,J. and Lenoir,G.M. (1996) A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am. J. Hum. Genet., 58, 42-51.
38. Serova,O.M., Mazoyer,S., Puget,N., Dubois,V., Tonin,P., Shugart,Y.Y., Goldgar,D., Narod,S.A., Lynch,H.T. and Lenoir,G.M. (1997) Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am. J. Hum. Genet., 60, 486-495.
39. Puget,N., Torchard,D., Serova-Sinilnikova,O.M., Lynch,H.T., Feunteun,J., Lenoir,G.M. and Mazoyer,S. (1997) A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res., 57, 828-831.
40. Mazoyer,S., Puget,N., Perrin-Vidoz,L., Lynch,H.T., Serova-Sinilnikova,O.M. and Lenoir,G.M. (1998) A BRCA1 nonsense mutation causes exon skipping. Am. J. Hum. Genet., 62, 713-715.
41. Puget,N., Stoppa-Lyonnet,D., Sinilnikova,O.M., Pages,S., Lynch,H.T., Lenoir,G.M. and Mazoyer,S. (1999) Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res., 59, 455-461.
42. Puget,N., Sinilnikova,O.M., Stoppa-Lyonnet,D., Audoynaud,C., Pages,S., Lynch,H.T., Goldgar,D., Lenoir,G.M. and Mazoyer,S. (1999) An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am. J. Hum. Genet., 64, 300-302.
43. Puget,N., Gad,S., Perrin-Vidoz,L., Sinilnikova,O.M., Stoppa-Lyonnet,D., Lenoir,G.M. and Mazoyer,S. (2002) Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am. J. Hum. Genet., 70, 858-865.
44. Angele,S., Romestaing,P., Moullan,N. et al. (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res., 63, 8717-8725.
45. Rozen,S. and Skaletsky,H.J. (2000) Primer3 on the WWW for general users and for biologist programmers. In Krawetz,S., Misener,S., Totowa,N.J. (eds) Bioinformatics Methods and Protocols: Methods in Molecular Biology. Humana Press, Totowa, NJ, pp. 365-386.
46. Abecasis,G.R. and Cookson,W.O.C. (2000) GOLD - Graphical overview of linkage disequilibrium. Bioinformatics, 16, 182-183.
47. Stram,D.O., Haiman,C.A., Kolonel,L.N., Henderson,B.E. and Pike,M.C. (2003) Choosing haplotype-tagging snps based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the multiethnic cohort study. Hum. Hered., 55, 27-36.
48. Antonarakis,S.E. (1998) Recommendations for a nomenclature system for human gene mutations. Hum. Mutat., 11, 1-3.
49. den Dunnen,J.T. and Antonarakis,S.E. (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat., 15, 7-12.
50. Magaria,M.M., Lin,S.S., Dooley,K.A. and Osborne,T.F. (1997) Sterol regulation of acetyl coenzyme A carboxylase promoter requires two interdependent binding sites for sterol regulatory element binding proteins. J. Lipid. Res., 38, 1630-1638.
51. Miller,M.P. and Kumar,S. (2001) Understanding human disease mutations through the use of interspecific genetic variation. Hum. Mol. Genet., 10, 2319-2328.
52. Shurbaji,M.S., Kalbfleisch,J.H. and Thurmond,T.S. (1996) Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum. Pathol., 27 917-21.
53. Rashid,A., Pizer,E.S., Moga,M., Milgraum,L.Z., Zahurak,M., Pasternack,G.R., Kuhajda,F.P. and Hamilton,S.R. (1997) Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am. J. Pathol., 150, 201-208.
54. Pizer,E.S., Lax,S.F., Kuhajda,F.P., Pasternack,G.R. and Kurman,R.J. (1998) Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer, 83, 528-537.
55. Swinnen,J.V., Vanderhoydonc,F., Elgamal,A.A. et al. (2000) Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int. J. Cancer, 88, 176-179.
56. Swinnen,J.V., Roskams,T., Joniau,S., Van Poppel,H., Oyen,R., Baert,L., Heyns,W. and Verhoeven,G. (2002) Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int. J. Cancer, 98, 19-22.
57. Kuhajda,F.P. (2000) Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition, 16, 202-208.
58. Ford,D., Easton,D.F., Bishop,D.T., Narod,S.A. and Goldgar,D.E. (1994) Risks of cancer in BRCA1-mutation carriers Breast Cancer Linkage Consortium. Lancet, 343, 692-695.
59. Thompson,D., Easton,D.F. and Breast Cancer Linkage Consortium. (2002) Cancer Incidence in BRCA1 mutation carriers. J. Natl Cancer Inst., 94, 1358-1365.